PressSeptember 3, 2020 Havn Life Sciences Announces Filing of Final Prospectus and Conditional Approval for Listing on CSE
BlogSeptember 3, 2020 Numinus Announces Filing of Final Short Form Prospectus for Offering of up to $4,000,000
Psychedelic NewsSeptember 2, 2020 The Beckley Foundation Launches Online Study to Assess Microdosing For Pain Management
PressSeptember 2, 2020 MagicMed Industries Closes Oversubscribed Private Placement for $1,642,880 with Mackie Research Capital Corporation
PressSeptember 2, 2020 Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder
PressSeptember 1, 2020 Better Plant Sciences Adds eCommerce Sales of 200 Plant-Based Products Through Agreement with JUSU
PressAugust 31, 2020 Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
PressAugust 28, 2020 Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence
PressAugust 28, 2020 New Wave Holdings Announces Definitive Agreement to Acquire Additional 25% Interest in Anahit Therapeutics
PressAugust 27, 2020 Better Plant Sciences Announces Website Launch and Strategic Plan to Grow Direct-to-Consumer Sales
PressAugust 26, 2020 Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
PressAugust 25, 2020 PSYC Continuing Its Path of Becoming Content Leader in The Psychedelic Space Through Key Interviews
PressAugust 24, 2020 Ehave Announces Plans to Accelerate the Monetization of its Proprietary Digital Health Platform
PressAugust 24, 2020 Field Trip Psychedelics Inc. Announces Closing of $11.0 million Financing, Entry into Amalgamation Agreement with Newton Energy Corporation
PressAugust 21, 2020 ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines
